vs
Side-by-side financial comparison of Beam Global (BEEM) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $9.0M, roughly 1.0× Beam Global). Beam Global runs the higher net margin — -25.8% vs -234.3%, a 208.5% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 6.7%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -21.2%).
Suntory Global Spirits Inc., formerly known as Beam Suntory, Inc., and before that as Beam, Inc., is an American beverage company that is a subsidiary of Suntory Holdings, a Japanese multinational beverage conglomerate. The company produces alcoholic beverages.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
BEEM vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $9.0M | $9.2M |
| Net Profit | $-2.3M | $-21.7M |
| Gross Margin | 17.8% | — |
| Operating Margin | -29.3% | -258.2% |
| Net Margin | -25.8% | -234.3% |
| Revenue YoY | 6.7% | 223.8% |
| Net Profit YoY | 49.6% | -11.1% |
| EPS (diluted) | — | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.0M | $9.2M | ||
| Q3 25 | $5.8M | $8.2M | ||
| Q2 25 | $7.1M | $7.6M | ||
| Q1 25 | $6.3M | $6.0M | ||
| Q4 24 | $8.5M | $2.9M | ||
| Q3 24 | $11.5M | $7.8M | ||
| Q2 24 | $14.8M | $6.9M | ||
| Q1 24 | $14.6M | $5.0M |
| Q4 25 | $-2.3M | $-21.7M | ||
| Q3 25 | $-4.9M | $-15.8M | ||
| Q2 25 | $-4.3M | $-17.9M | ||
| Q1 25 | $-15.5M | $-18.8M | ||
| Q4 24 | $-4.6M | $-19.5M | ||
| Q3 24 | $1.3M | $-19.1M | ||
| Q2 24 | $-4.9M | $-23.0M | ||
| Q1 24 | $-3.0M | $-25.0M |
| Q4 25 | 17.8% | — | ||
| Q3 25 | -0.5% | — | ||
| Q2 25 | 20.3% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 15.9% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | -29.3% | -258.2% | ||
| Q3 25 | -84.2% | -226.9% | ||
| Q2 25 | -63.1% | -279.2% | ||
| Q1 25 | -245.8% | -385.0% | ||
| Q4 24 | -60.1% | -840.5% | ||
| Q3 24 | 11.2% | -305.5% | ||
| Q2 24 | -32.3% | -386.6% | ||
| Q1 24 | -20.9% | -558.3% |
| Q4 25 | -25.8% | -234.3% | ||
| Q3 25 | -84.1% | -194.4% | ||
| Q2 25 | -60.5% | -237.3% | ||
| Q1 25 | -245.5% | -316.4% | ||
| Q4 24 | -54.5% | -682.9% | ||
| Q3 24 | 11.3% | -244.9% | ||
| Q2 24 | -33.2% | -333.6% | ||
| Q1 24 | -20.9% | -495.4% |
| Q4 25 | — | $-0.35 | ||
| Q3 25 | $-0.28 | $-0.25 | ||
| Q2 25 | $-0.28 | $-0.28 | ||
| Q1 25 | $-1.04 | $-0.30 | ||
| Q4 24 | $-0.31 | $-0.23 | ||
| Q3 24 | $0.09 | $-0.31 | ||
| Q2 24 | $-0.34 | $-0.45 | ||
| Q1 24 | $-0.21 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $969.0K | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $24.8M | $-108.5M |
| Total Assets | $42.7M | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $969.0K | $80.9M | ||
| Q3 25 | $3.3M | $89.3M | ||
| Q2 25 | — | $72.6M | ||
| Q1 25 | — | $61.0M | ||
| Q4 24 | $4.6M | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
| Q4 25 | $24.8M | $-108.5M | ||
| Q3 25 | $26.5M | $-89.7M | ||
| Q2 25 | $26.9M | $-76.7M | ||
| Q1 25 | $26.7M | $-61.7M | ||
| Q4 24 | $41.3M | $-45.5M | ||
| Q3 24 | $46.4M | $-28.3M | ||
| Q2 24 | $43.4M | $-14.3M | ||
| Q1 24 | $46.9M | $-97.5M |
| Q4 25 | $42.7M | $198.1M | ||
| Q3 25 | $44.6M | $205.0M | ||
| Q2 25 | $46.7M | $226.2M | ||
| Q1 25 | $46.8M | $258.7M | ||
| Q4 24 | $61.5M | $284.0M | ||
| Q3 24 | $67.3M | $308.4M | ||
| Q2 24 | $71.9M | $328.6M | ||
| Q1 24 | $75.7M | $255.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-3.8M | $-22.3M |
| Free Cash FlowOCF − Capex | $-3.8M | — |
| FCF MarginFCF / Revenue | -42.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.8M | $-22.3M | ||
| Q3 25 | $-4.6M | $-18.9M | ||
| Q2 25 | $-318.0K | $-21.0M | ||
| Q1 25 | $-1.8M | $-24.0M | ||
| Q4 24 | $859.0K | $-24.5M | ||
| Q3 24 | $-3.0M | $-21.0M | ||
| Q2 24 | $2.9M | $-25.5M | ||
| Q1 24 | $-3.0M | $-29.3M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-1.1M | $-21.0M | ||
| Q1 25 | $-1.8M | $-24.0M | ||
| Q4 24 | $462.0K | $-25.0M | ||
| Q3 24 | $-3.1M | $-21.3M | ||
| Q2 24 | $2.8M | $-25.6M | ||
| Q1 24 | $-3.1M | $-29.4M |
| Q4 25 | -42.3% | — | ||
| Q3 25 | -87.9% | — | ||
| Q2 25 | -15.2% | -278.2% | ||
| Q1 25 | -28.7% | -403.2% | ||
| Q4 24 | 5.4% | -875.3% | ||
| Q3 24 | -27.4% | -273.0% | ||
| Q2 24 | 18.9% | -371.0% | ||
| Q1 24 | -21.5% | -583.1% |
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 7.8% | 0.0% | ||
| Q2 25 | 10.7% | 0.3% | ||
| Q1 25 | 0.9% | 0.5% | ||
| Q4 24 | 4.7% | 16.8% | ||
| Q3 24 | 1.7% | 4.0% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 0.7% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BEEM
| Products | $7.0M | 77% |
| Other | $2.0M | 23% |
FHTX
Segment breakdown not available.